Andere Sprachen Shattuck Labs, Inc.

Aktien

A2QD61

US82024L1035

STTK

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
9.9 ^USD	+4.32%		+10.24%	+38.85%

04.03.	Shattuck Labs, Inc. gibt Vorstandsernennungen bekannt	CI
01.03.	Sektor-Update: Aktien des Gesundheitswesens steigen am späten Nachmittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024	09.04.
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference	01.04.
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	04.03.
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	04.03.
Shattuck Labs, Inc. Announces Board Appointments	04.03.
Sector Update: Health Care Stocks Rising Late Afternoon	01.03.
Sector Update: Health Care Stocks Advance Friday Afternoon	01.03.
Shattuck Labs Shares Rise as Q4 Net Loss Narrows	01.03.
Shattuck Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	29.02.
Shattuck Labs, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	29.02.
Shattuck Labs Announces Participation in Upcoming March Conferences	26.02.
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	14.02.
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins	14.02.
Shattuck Strikes Joint Development Deal With Japan's Ono Pharma	13.02.
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	13.02.
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	13.02.
Shattuck Labs, Inc. Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	13.02.
Shattuck Labs Insider Sold Shares Worth $250,000, According to a Recent SEC Filing	16.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Shattuck Labs, Inc.

Aktien

A2QD61

US82024L1035

STTK

Andere Sprachen

Filter